$15.79
0.191.22%
Last update: Nov 9, 4:00 PM
Yarrow Bioscience Inc
YARWNASDAQ
Yarrow Bioscience fell 13.0% from $18.15 to $15.79, behind the S&P 500's +10.5%. Its worst day was Jul 23 (−42.0%), and its low came Nov 5 at $13.60.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Yarrow Bioscience shares rose 49.0%, while the S&P 500 fell 1.1%.
+49.0%, the year's best day, on 5M shares, the year's heaviest volume · S&P 500 −1.1%
Yarrow Bioscience closed at its highest level of the year, 147.3% above where the year started.
Story events cover the past 12 months · Times ET
+0.5% · S&P 500 −0.1%
EPS of $-2.14 missed the $-0.22 estimate on $0.00 revenue.
+0.5% · S&P 500 +0.7%
Yarrow Bioscience shares rose 17.9%, while the S&P 500 rose 0.9%.
+17.9% · S&P 500 +0.9%
Yarrow Bioscience shares fell 18.8%, while the S&P 500 rose 1.7%.
−18.8% · S&P 500 +1.7%
Where it ended: a close of $15.79 on Nov 9, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $-0.32).
Nothing in the past 12 months.
All YARW dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for YARW and SPY from Benzinga historical bars. Not investment advice.
